R Don Elsey's Net Worth
$1.46 Million
Who is R Don Elsey?
R Don Elsey has an estimated net worth of $1.46 Million. This is based on reported shares across multiple companies, which include BullFrog AI Holdings, Inc., Senseonics Holdings, Inc., Emergent BioSolutions Inc., OPGEN INC, REGENERX BIOPHARMACEUTICALS INC, Lyra Therapeutics, Inc., and Regado Biosciences Inc.
SEC CIK
R Don Elsey's CIK is 0001380742
Past Insider Trading and Trends
2008 was R Don Elsey's most active year for acquiring shares with 11 total transactions. R Don Elsey's most active month to acquire stocks was the month of February. 2009 was R Don Elsey's most active year for disposing of shares, totalling 65 transactions. R Don Elsey's most active month to dispose stocks was the month of February. 2013 saw R Don Elsey paying a total of $416,665,000.00 for 83,333 shares, this is the most they've acquired in one year. In 2011 R Don Elsey cashed out on 29,740 shares for a total of $380,140.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BullFrog AI Holdings, Inc. (BFRG) Snapshot price: $2.29
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Senseonics Holdings, Inc. (SENS) Snapshot price: $0.338
CFO, Secretary and Treasurer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Emergent BioSolutions Inc. (EBS) Snapshot price: $7.55
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +25.37% | 5.38K |
$16.05 | -$12,278.25 | 26.61K |
Mar 13 - Mar 14
| |||
Form 4
| -4.37% | -970.00 |
$14.49 | -$14,055.30 | 21.23K |
Mar 8
| |||
Form 4
|
—
|
0
|
$19.13 | -$168,879.90 | 22.2K |
Scheduled
|
Apr 15
| ||
Form 4
| +49.50% | 7.35K |
—
|
—
| 22.2K |
Mar 15
| |||
Form 4
| -6.13% | -970.00 |
$21.15 | -$20,515.50 | 14.85K |
Mar 8
| |||
Form 4
| +1,666.67% | 5K |
$3.50 | $17,500.00 | 5.3K |
Apr 13
| |||
Form 4
| +776.58% | 9.32K |
—
|
—
| 10.52K |
Mar 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
| -75.00% | -900.00 |
$19.91 | -$17,919.00 | 300 |
Scheduled
|
Mar 10
| ||
Form 4
| -86.42% | -7.63K |
$19.68 | -$150,271.24 | 1.2K |
Scheduled
|
Mar 11
| ||
Form 4
| +2,844.67% | 8.53K |
$13.14 | -$11,406.59 | 8.83K |
Scheduled
|
Mar 10
| ||
Form 4
|
—
|
0
|
$16.10 | -$119,344.90 | 300 |
Scheduled
|
Dec 12
| ||
Form 4
|
—
|
0
|
$17.63 | -$121,861.82 | 300 |
Scheduled
|
Nov 26
| ||
Form 4/A
|
—
|
0
|
$10.25 | -$59,197.50 | 300 |
Scheduled
|
Oct 17
| ||
Form 4/A
|
—
|
0
|
$12.09 | -$117,610.38 | 300 |
Scheduled
|
Oct 20 - Oct 21
| ||
Form 4
|
—
|
0
|
$16.50 | -$223,468.72 | 300 |
Scheduled
|
Nov 10
| ||
Form 4
|
—
|
0
|
$12.09 | -$117,610.38 | 300 |
Scheduled
|
Oct 20 - Oct 21
| ||
Form 4
|
—
|
0
|
$9.99 | -$121,697.50 | 300 |
Scheduled
|
Oct 17
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
∞
| 300 |
$11.45 | $3,435.00 | 300 |
Sep 20 - Nov 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
OPGEN INC (OPGN) Snapshot price: $2.05
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +95.24% | 1.5K |
—
|
—
| 3.08K |
Jun 7
| |||
Form 4
| +90.91% | 15K |
—
|
—
| 31.5K |
Jun 9
| |||
Form 4
| +50.00% | 15K |
—
|
—
| 45K |
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
∞
| 30K |
—
|
—
| 30K |
May 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
REGENERX BIOPHARMACEUTICALS INC (RGRXD) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
|
∞
| 104.46K |
$0.06 | $6,267.36 | 104.46K |
Sep 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |